Treatment of resistant pain in hypertrophic pulmonary arthropathy with ketorolac.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8511741.
- Also identified by PMC identifier 464442.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pain associated with hypertrophic pulmonary osteoarthropathy (HPOA) may be extremely disabling and resistant to treatment. The successful use of ketorolac, a new non-steroidal anti-inflammatory drug, given by subcutaneous infusion is reported in two patients with uncontrolled pain caused by HPOA.
Medical subject headings
- Anti-Inflammatory Agents, Non-Steroidal
- Osteoarthropathy, Secondary Hypertrophic
- Pain
- Tolmetin